Neuland Laboratories receives EIR from USFDA for Bonthapally facility

30 Aug 2019

Neuland Laboratories has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility located at Bonthapally, Hyderabad. The facility was inspected from June 17, 2019 to June 21, 2019.

Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.

Related Neuland Laboratories Ltd. Links:

Neuland Laboratories Share Price

1202.25 13.80 (1.16%) Oct 23, 18:03
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 484.35
Dr. Reddys Lab 5015.90
Lupin 990.75
Piramal Enterprises 1327.45
Cadila Healthcare 423.85
View more..
Sensex vs Neuland Laboratories
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback